Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer ; volume:33 ; number:1 ; day:22 ; month:8 ; year:2014 ; pages:1-6 ; date:12.2014
Journal of experimental & clinical cancer research ; 33, Heft 1 (22.8.2014), 1-6, 12.2014
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Lin, Ying-Li
Wang, Yan-Ling
Ma, Jian-Guo
Li, Wen-Ping
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-014-0068-7
- URN
-
urn:nbn:de:101:1-2019060923363518673679
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lin, Ying-Li
- Wang, Yan-Ling
- Ma, Jian-Guo
- Li, Wen-Ping
- SpringerLink (Online service)
Ähnliche Objekte (12)
Clinical significance of subepithelial growth patterns in non-muscle invasive bladder cancer
Clinical significance of CDH13 promoter methylation as a biomarker for bladder cancer: a meta-analysis
Prognostic significance of SNCA and its methylation in bladder cancer
FOXM1 predicts disease progression in non-muscle invasive bladder cancer
Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma
Significance of promoter methylation of multiple tumor suppressor genes in hepatocellular carcinoma
Follow-up in non-muscle invasive bladder cancer: facts and future
A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients
Prognostic significance of factor XIIIA promoter methylation status in aneurysmal subarachnoid haemorrhage (aSAH)
Metastatic non-muscle invasive transitional cell carcinoma of urinary bladder: a case report
Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer
Precise grading of non-muscle invasive bladder cancer with multi-scale pyramidal CNN
Clinical significance of subepithelial growth patterns in non-muscle invasive bladder cancer
Clinical significance of CDH13 promoter methylation as a biomarker for bladder cancer: a meta-analysis
Prognostic significance of SNCA and its methylation in bladder cancer
FOXM1 predicts disease progression in non-muscle invasive bladder cancer
Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma
Significance of promoter methylation of multiple tumor suppressor genes in hepatocellular carcinoma
Follow-up in non-muscle invasive bladder cancer: facts and future
A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients
Prognostic significance of factor XIIIA promoter methylation status in aneurysmal subarachnoid haemorrhage (aSAH)
Metastatic non-muscle invasive transitional cell carcinoma of urinary bladder: a case report
Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer
Precise grading of non-muscle invasive bladder cancer with multi-scale pyramidal CNN
Clinical significance of subepithelial growth patterns in non-muscle invasive bladder cancer
Clinical significance of CDH13 promoter methylation as a biomarker for bladder cancer: a meta-analysis
Prognostic significance of SNCA and its methylation in bladder cancer
FOXM1 predicts disease progression in non-muscle invasive bladder cancer
Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma
Significance of promoter methylation of multiple tumor suppressor genes in hepatocellular carcinoma
Follow-up in non-muscle invasive bladder cancer: facts and future
A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients
Prognostic significance of factor XIIIA promoter methylation status in aneurysmal subarachnoid haemorrhage (aSAH)
Metastatic non-muscle invasive transitional cell carcinoma of urinary bladder: a case report
Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer